Advertisement
Screener

IDEAYA Biosciences, Inc. (IDYA) Other

IDEAYA Biosciences, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2023-11-07: Form 10-Q; Item Smaller reporting company; As filed Yes.
  • 2023-11-07: Form 10-Q; Item Emerging growth company; As filed Yes.
  • 2023-08-10: Form 10-Q; Item Smaller reporting company; As filed Yes.
  • 2023-08-10: Form 10-Q; Item Emerging growth company; As filed Yes.
FiledFormItemAs filed
2023-11-0710-QSmaller reporting companyYes
2023-11-0710-QEmerging growth companyYes
2023-08-1010-QSmaller reporting companyYes
2023-08-1010-QEmerging growth companyYes
2023-05-0910-QSmaller reporting companyYes
2023-05-0910-QEmerging growth companyYes
2023-03-0710-KSmaller reporting companyYes
2023-03-0710-KEmerging growth companyYes
2023-03-0710-KWell-known seasoned issuerNo
2022-11-0810-QSmaller reporting companyYes
2022-11-0810-QEmerging growth companyYes
2022-08-1510-QSmaller reporting companyYes
2022-08-1510-QEmerging growth companyYes
2022-05-1010-QSmaller reporting companyYes
2022-05-1010-QEmerging growth companyYes
2022-03-1810-KSmaller reporting companyYes
2022-03-1810-KEmerging growth companyYes
2022-03-1810-KWell-known seasoned issuerNo
2021-11-1510-QSmaller reporting companyYes
2021-11-1510-QEmerging growth companyYes
2021-08-1010-QSmaller reporting companyYes
2021-08-1010-QEmerging growth companyYes
2021-05-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2021-05-1010-QSmaller reporting companyYes
2021-05-1010-QEmerging growth companyYes
2021-03-2310-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2021-03-2310-KSmaller reporting companyYes
2021-03-2310-KEmerging growth companyYes
2021-03-2310-KWell-known seasoned issuerNo
2020-11-1210-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2020-11-1210-QSmaller reporting companyYes
2020-11-1210-QEmerging growth companyYes
2020-08-1210-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2020-08-1210-QSmaller reporting companyYes
2020-08-1210-QEmerging growth companyYes
2020-05-1210-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2020-05-1210-QSmaller reporting companyYes
2020-05-1210-QEmerging growth companyYes
2020-03-2410-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2020-03-2410-KSmaller reporting companyYes
2020-03-2410-KEmerging growth companyYes
2020-03-2410-KWell-known seasoned issuerNo
2019-11-1310-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · IDYA · NASDAQ
2019-11-1310-QSmaller reporting companyYes
2019-11-1310-QEmerging growth companyYes
2019-08-1210-QSmaller reporting companyYes
2019-08-1210-QEmerging growth companyYes
2019-08-1210-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53